← Back to Search

Imaging Device

Real-time Eye Tracking and Imaging of the Eye in Diabetic Retinopathy Patients

N/A
Waitlist Available
Research Sponsored by PulseMedica
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through study completion, an average of 6 months
Awards & highlights
No Placebo-Only Group

Summary

This trial is testing a new camera called the OSNAT800 IO that takes 3D pictures of the back of the eye and tracks eye movements in real-time. It aims to help doctors monitor patients with diabetic retinopathy, a common cause of vision loss. The goal is to see if this device can accurately track eye movements while taking detailed images.

Eligible Conditions
  • Diabetic Retinopathy
  • Retinal Imaging

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study completion, an average of 6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and through study completion, an average of 6 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Successful performance of the real-time eye tracking function by post-image processing
Secondary study objectives
Device usability as assessed by a survey
Image Quality as assessed by user assessment of image quality parameters

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Retinal Imaging using the OSNAT800 IO deviceExperimental Treatment1 Intervention
Patients will have their eyes imaged with the OSNAT800 IO device in addition to a routine standard of care appointment.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
OSNAT 800 IO
2022
N/A
~60

Find a Location

Who is running the clinical trial?

PulseMedicaLead Sponsor
2 Previous Clinical Trials
275 Total Patients Enrolled
~18 spots leftby Dec 2025